TVUS is the recommended initial investigation for PMB, unless there are contraindications. This is because it provides the most accurate measurement of endometrial thickness, which is crucial in determining if the bleeding is due to endometrial cancer.

Understanding Postmenopausal Bleeding

Postmenopausal bleeding refers to vaginal bleeding that occurs after a woman has gone 12 months without a menstrual period. While most cases do not involve cancer, it is important to rule out this possibility in all women. The most common cause of postmenopausal bleeding is vaginal atrophy, which occurs due to a reduction in estrogen following menopause. Other causes include hormone replacement therapy, endometrial hyperplasia, endometrial cancer, cervical cancer, ovarian cancer, and vaginal cancer.

To investigate postmenopausal bleeding, women over the age of 55 should undergo an ultrasound within two weeks to check for endometrial cancer. If referred on a cancer pathway, a transvaginal ultrasound is the preferred method of investigation. Treatment options depend on the underlying cause of the bleeding. For vaginal atrophy, topical estrogen and lifestyle changes can help alleviate symptoms, while HRT may also be used. If the bleeding is due to a specific type of HRT, switching to a different preparation may be helpful. In cases of endometrial hyperplasia, dilation and curettage may be necessary to remove excess tissue.

Overall, it is important for women experiencing postmenopausal bleeding to seek medical attention and undergo appropriate testing to rule out any serious underlying conditions.

According to NICE guidelines, an endometrial biopsy should be performed if necessary to rule out endometrial cancer or atypical hyperplasia. The biopsy is recommended for women who experience persistent intermenstrual bleeding and for those aged 45 and above who have had unsuccessful or ineffective treatment. In the case of the patient mentioned above, her treatment has not been successful and she has a thickened endometrium. Although there is some debate about the thickness of the endometrium in premenopausal women, this patient qualifies for a biopsy based on her failed medical treatment alone, making it the most appropriate option.

Endometrial cancer is a type of cancer that is commonly found in women who have gone through menopause, but it can also occur in around 25% of cases before menopause. The prognosis for this type of cancer is usually good due to early detection. There are several risk factors associated with endometrial cancer, including obesity, nulliparity, early menarche, late menopause, unopposed estrogen, diabetes mellitus, tamoxifen, polycystic ovarian syndrome, and hereditary non-polyposis colorectal carcinoma. Postmenopausal bleeding is the most common symptom of endometrial cancer, which is usually slight and intermittent initially before becoming more heavy. Pain is not common and typically signifies extensive disease, while vaginal discharge is unusual.

When investigating endometrial cancer, women who are 55 years or older and present with postmenopausal bleeding should be referred using the suspected cancer pathway. The first-line investigation is trans-vaginal ultrasound, which has a high negative predictive value for a normal endometrial thickness (< 4 mm). Hysteroscopy with endometrial biopsy is also commonly used for investigation. The management of localized disease involves total abdominal hysterectomy with bilateral salpingo-oophorectomy, while patients with high-risk disease may have postoperative radiotherapy. progesterone therapy is sometimes used in frail elderly women who are not considered suitable for surgery. It is important to note that the combined oral contraceptive pill and smoking are protective against endometrial cancer.

Appropriate Treatment Options for Vaginal Infections

Bacterial vaginosis is a common vaginal infection that results in a decrease in lactobacilli and an increase in anaerobic bacteria. The typical symptoms include a white, milky, non-viscous discharge with a fishy odor and a pH greater than 4.5. The recommended treatment for bacterial vaginosis is metronidazole 400 mg twice a day for a week.

Azithromycin is the treatment of choice for Chlamydia, but it is not appropriate for bacterial vaginosis. acyclovir is used to treat herpes infections, which is not the cause of this patient’s symptoms. Fluconazole is a treatment option for vaginal candidiasis, but it is unlikely to be the cause of this patient’s symptoms. Pivmecillinam is used to treat urinary tract infections, which is not the cause of this patient’s symptoms.

In conclusion, the appropriate treatment for bacterial vaginosis is metronidazole, and other treatments should be considered based on the specific diagnosis.

The luteal phase of the menstrual cycle remains constant at 14 days, while the follicular phase can vary. The serum progesterone level reaches its peak 7 days after ovulation. For a 35-day cycle, the follicular phase would be 21 days (with ovulation occurring on day 21) and the luteal phase would be 14 days, resulting in the progesterone level peaking on day 28 (35-7). However, relying on day 21 progesterone levels would only be useful for women with a regular menstrual cycle of 28 days. While basal body temperature charting can be used to track ovulation, it is not the recommended method by NICE. An increase in basal temperature after ovulation can indicate successful ovulation.

Infertility is a common issue that affects approximately 1 in 7 couples. It is important to note that around 84% of couples who have regular sexual intercourse will conceive within the first year, and 92% within the first two years. The causes of infertility can vary, with male factor accounting for 30%, unexplained causes accounting for 20%, ovulation failure accounting for 20%, tubal damage accounting for 15%, and other causes accounting for the remaining 15%.

When investigating infertility, there are some basic tests that can be done. These include a semen analysis and a serum progesterone test. The serum progesterone test is done 7 days prior to the expected next period, typically on day 21 for a 28-day cycle. The interpretation of the serum progesterone level is as follows: if it is less than 16 nmol/l, it should be repeated and if it remains consistently low, referral to a specialist is necessary. If the level is between 16-30 nmol/l, it should be repeated, and if it is greater than 30 nmol/l, it indicates ovulation.

It is important to counsel patients on lifestyle factors that can impact fertility. This includes taking folic acid, maintaining a healthy BMI between 20-25, and advising regular sexual intercourse every 2 to 3 days. Additionally, patients should be advised to quit smoking and limit alcohol consumption to increase their chances of conceiving.

The Most Appropriate Initial Investigation for Amenorrhoea: Urine Pregnancy Test

When a patient presents with amenorrhoea, the most appropriate initial investigation is always a pregnancy test. If pregnancy is excluded, further investigations may be necessary to determine the underlying cause. For example, a diagnosis of polycystic ovary syndrome (PCOS) may be supported by high levels of free testosterone with low levels of sex-hormone binding globulin, which can be tested after excluding pregnancy. A pelvic ultrasound is also a useful investigation for PCOS and should be done following β-HCG estimation. While a raised LH: FSH ratio may be suggestive of PCOS, it is not diagnostic and not the initial investigation of choice here. Similarly, an oral glucose tolerance test might be useful in patients diagnosed with PCOS, but it would not be an appropriate initial investigation. Therefore, a urine pregnancy test is the most important first step in investigating amenorrhoea.

Due to a weakened immune response and reduced clearance of the human papillomavirus, women who are HIV positive face an elevated risk of cervical intra-epithelial neoplasia (CIN) and cervical cancer. If HIV positive women have low-grade lesions (CIN1), these lesions may not clear and could progress to high-grade CIN or cervical cancer. Even with effective antiretroviral treatment, these women still have a high risk of abnormal cytology and an increased risk of false-negative results. Therefore, it is recommended that women with HIV receive cervical cytology at the time of diagnosis and annually thereafter for screening purposes.

Understanding Cervical Cancer: Risk Factors and Mechanism of HPV

Cervical cancer is a type of cancer that affects the cervix, which is the lower part of the uterus. It is most commonly diagnosed in women under the age of 45, with the highest incidence rates occurring in those aged 25-29. The cancer can be divided into two types: squamous cell cancer and adenocarcinoma. Symptoms may include abnormal vaginal bleeding, postcoital bleeding, intermenstrual bleeding, or postmenopausal bleeding, as well as vaginal discharge.

The most important factor in the development of cervical cancer is the human papillomavirus (HPV), particularly serotypes 16, 18, and 33. Other risk factors include smoking, human immunodeficiency virus, early first intercourse, many sexual partners, high parity, and lower socioeconomic status. While the association between combined oral contraceptive pill use and cervical cancer is sometimes debated, a large study published in the Lancet confirmed the link.

The mechanism by which HPV causes cervical cancer involves the production of oncogenes E6 and E7 by HPV 16 and 18, respectively. E6 inhibits the p53 tumour suppressor gene, while E7 inhibits the RB suppressor gene. Understanding the risk factors and mechanism of HPV in the development of cervical cancer is crucial for prevention and early detection. Regular cervical cancer screening is recommended for all women.

According to the BNF, the copper intra-uterine device is the most efficient option for emergency contraception and should be offered to all eligible women seeking such services. Unlike other medications, its effectiveness is not influenced by BMI. Additionally, it provides long-term contraception, which is an added advantage for the patient. If the copper intra-uterine device is not appropriate or acceptable to the patient, oral hormonal emergency contraception should be offered. However, the effectiveness of these contraceptives is reduced in patients with a high BMI. A double dose of levonorgestrel is recommended for patients with a BMI of over 26 kg/m² or body weight greater than 70kg. It is unclear which of the two oral hormonal contraceptives is more effective for patients with a raised BMI. The levonorgestrel intrauterine system and ethinylestradiol with levonorgestrel are not suitable for emergency contraception. In conclusion, the copper intrauterine device is the most effective method for this patient because it is not affected by BMI, unlike oral hormonal emergency contraceptives.

Emergency contraception is available in the UK through two methods: emergency hormonal contraception and intrauterine device (IUD). Emergency hormonal contraception includes two types of pills: levonorgestrel and ulipristal. Levonorgestrel works by stopping ovulation and inhibiting implantation, while ulipristal primarily inhibits ovulation. Levonorgestrel should be taken as soon as possible after unprotected sexual intercourse, within 72 hours, and is 84% effective when used within this time frame. The dose should be doubled for those with a BMI over 26 or weight over 70kg. Ulipristal should be taken within 120 hours of intercourse and may reduce the effectiveness of hormonal contraception. The most effective method of emergency contraception is the copper IUD, which can be inserted within 5 days of unprotected intercourse or up to 5 days after the likely ovulation date. It may inhibit fertilization or implantation and is 99% effective regardless of where it is used in the cycle. Prophylactic antibiotics may be given if the patient is at high risk of sexually transmitted infection.

Intersex and Genetic Disorders: Understanding the Different Types

Intersex conditions and genetic disorders can affect an individual’s physical and biological characteristics. Understanding the different types can help in diagnosis and treatment.

Male Pseudointersex
Male pseudointersex is a condition where an individual has a 46XY karyotype and testes but presents phenotypically as a woman. This is caused by androgen insensitivity, deficit in testosterone production, or deficit in dihydrotestosterone production. Androgen insensitivity syndrome is the most common mechanism, which obstructs the development of male genitalia and secondary sexual characteristics, resulting in a female phenotype.

True Intersex
True intersex is when an individual carries both male and female gonads.

Female Intersex
Female intersex is a term used to describe an individual who is phenotypically male but has a 46XX genotype and ovaries. This is usually due to hyperandrogenism or a deficit in estrogen synthesis, leading to excessive androgen synthesis.

Fragile X Syndrome
Fragile X syndrome is an X-linked dominant disorder that affects more men than women. It is associated with a long and narrow face, large ears, large testicles, significant intellectual disability, and developmental delay. The karyotype correlates with the phenotype and gonads.

Turner Syndrome
Turner syndrome is associated with the genotype 45XO. Patients are genotypically and phenotypically female, missing part of, or a whole, X chromosome. They have primary or secondary amenorrhea due to premature ovarian failure and failure to develop secondary sexual characteristics.

Types of Ectopic Pregnancy in the Fallopian Tube

Ectopic pregnancy, a condition where the fertilized egg implants outside the uterus, can occur in different parts of the Fallopian tube. Here are the different types of ectopic pregnancy in the Fallopian tube and their characteristics:

1. Isthmus – Ectopic pregnancy in the isthmus is rare but can occur. The tube is rigid, making rupture occur earlier than in other parts of the tube.

2. Interstitial part – This is the proximal segment of the tube embedded within the uterine wall. Ectopic pregnancy in this part is very rare and is more likely to occur in women who have had ipsilateral salpingectomy.

3. Ampulla – Ectopic pregnancy occurs most frequently in the ampullary part of the tube, which is relatively wide. Rupture usually occurs about 2 months after the last menstrual period, but it happens later than in the isthmus due to the elasticity of the tube.

4. Fimbrial end – Ectopic pregnancy near the fimbrial end can result in an ovarian pregnancy, which is rare and not associated with pelvic inflammatory disease or an intrauterine device.

5. Cornua – Pregnancy may implant itself in the cornua, which is the opening of the Fallopian tube. Combined with interstitial pregnancies, this represents a small percentage of all ectopic pregnancies.

Knowing the different types of ectopic pregnancy in the Fallopian tube can help in early detection and management of this potentially life-threatening condition.

The most common reason for delayed puberty in women is constitutional delay, which is a normal variation where puberty starts later than usual. This may be due to a family history of late menarche. However, it is important to refer the patient to a specialist for further investigation. Hypogonadotrophic hypogonadism is another cause, which is a result of a deficiency in gonadotrophin-releasing hormone secretion. This can be managed by restoring weight in cases such as athletes, dancers, or anorexia sufferers. Primary gonadal failure is rare and may occur in isolation or as part of chromosomal anomalies. Hormone replacement therapy is the treatment for this condition. Hyperprolactinaemia is a rare cause of primary amenorrhoea, which is caused by high levels of prolactin from a tumour. However, it is unlikely to affect normal development. Hypothyroidism can also cause amenorrhoea, but it is usually accompanied by other symptoms such as cold intolerance, mood changes, and weight gain.

The most appropriate method of HRT for the patient in this scenario is a transdermal oestrogen patch, as she has had a hysterectomy and oestrogen monotherapy is the regimen of choice. As the patient’s BMI is > 30 kg/m2, an oral oestrogen preparation is not recommended due to the increased risk of venous thromboembolism. HRT has benefits for the patient, including protection against osteoporosis, urogenital atrophy, and cardiovascular disorders. However, HRT also has risks, including an increased risk of venous thromboembolism and endometrial and breast cancer. Type 2 diabetes mellitus is not a contraindication to HRT, and there is no evidence that HRT affects glucose control. Combination HRT regimens are reserved for women with a uterus, and oral oestradiol once daily is not recommended for patients with a BMI > 30 kg/m2 due to the increased risk of venous thromboembolism. Women at high risk of developing venous thromboembolism or those with a strong family history or thrombophilia should be referred to haematology before starting HRT.

Hysterectomy: Antibiotic Prophylaxis and Surgical Considerations

Hysterectomy is a surgical procedure that involves the removal of the uterus and is commonly used to treat pelvic pathologies such as fibroids and adenomyosis. Antibiotic prophylaxis is crucial during the operation to prevent infection, and Co-amoxiclav ® is a broad-spectrum antibiotic that is commonly used. Complications of hysterectomy include haemorrhage, trauma to the bowel, damage to the urinary tract, infection, thromboembolic disease, and an increased risk of vaginal prolapse. Vaginal hysterectomy is preferred over abdominal hysterectomy as it reduces post-operative morbidity and has a shorter recovery time. The decision to remove ovaries during abdominal hysterectomy depends on various factors such as the patient’s age, family history of breast and ovarian cancer, and plans for hormone replacement therapy. Subtotal hysterectomy is an option for women with dysfunctional uterine bleeding who have normal cervical cytology. Intraoperative prophylactic-dose heparin is not recommended as it can cause excessive bleeding. Penicillin V and trimethoprim are not suitable for intraoperative prophylaxis as they do not provide broad-spectrum cover. Amoxicillin is inadequate for this operation as it does not provide the necessary prophylaxis during the intraoperative period.

Management Options for Urge Incontinence: Medications, Procedures, and Desmopressin

Urge incontinence is a common condition that can significantly impact a patient’s quality of life. While conservative treatments such as pelvic floor exercises and bladder training are often the first line of management, some patients may require additional interventions. Here are some options for managing urge incontinence:

Oxybutinin: This anticholinergic medication is often used as first-line treatment for urge incontinence that has not responded to conservative measures. It works by inhibiting muscarinic action on acetylcholine receptors, preventing muscle contraction. However, it is contraindicated in certain patients and can cause side effects such as dry mouth and constipation.

Percutaneous sacral nerve stimulation: This procedure involves a small stimulator that delivers stimulation to the sacral nerve, leading to contraction of the external sphincter and pelvic floor muscles. It is reserved for patients who have failed other treatments or cannot perform intermittent self-catheterization.

Augmentation cystoplasty: This surgical procedure is reserved for severe cases of urge incontinence that have not responded to other management options. It involves resecting a segment of the small bowel and suturing it to the bladder to increase its size. However, it is associated with numerous complications and requires follow-up.

Botulinum toxin: This is the first-line invasive management for patients who have not improved on anticholinergic medication or do not want drug therapy. It is injected into the bladder to inhibit the release of acetylcholine and provide symptom relief for up to six months.

Desmopressin: This synthetic analogue of antidiuretic hormone is used as second-line management for nocturia in patients with urge incontinence. It works by signaling the transportation of aquaporins in the collecting ducts of the kidney, leading to water reabsorption and less urine production. However, it is contraindicated in certain patients and can cause side effects such as hyponatremia and fluid retention.

In summary, there are several options for managing urge incontinence, ranging from medications to procedures. It is important to consider the patient’s individual needs and contraindications when selecting a treatment plan.

For women with atypical endometrial hyperplasia who are postmenopausal, it is recommended to undergo a total hysterectomy with bilateral salpingo-oophorectomy to prevent malignant progression. A total hysterectomy alone is not sufficient for postmenopausal women. It is also not recommended to undergo a bilateral salpingo-oophorectomy without removing the endometrium. A watch and wait approach is not advisable due to the potential for malignancy, and radiotherapy is not recommended as the condition is not yet malignant.

Endometrial hyperplasia is a condition where the endometrium, the lining of the uterus, grows excessively beyond what is considered normal during the menstrual cycle. This abnormal proliferation can lead to endometrial cancer in some cases. There are four types of endometrial hyperplasia: simple, complex, simple atypical, and complex atypical. Symptoms of this condition include abnormal vaginal bleeding, such as intermenstrual bleeding.

The management of endometrial hyperplasia depends on the type and severity of the condition. For simple endometrial hyperplasia without atypia, high dose progestogens may be prescribed, and repeat sampling is recommended after 3-4 months. The levonorgestrel intra-uterine system may also be used. However, if atypia is present, hysterectomy is usually advised.

According to NICE guidelines for cervical cancer screening, if the first repeat smear at 12 months is still positive for high-risk human papillomavirus (hrHPV), the next step is to repeat the smear 12 months later (i.e. at 24 months). If the patient remains hrHPV positive but cytology negative at 12 months, they should have another HPV test in a further 12 months. If the patient becomes hrHPV negative at 24 months, they can return to routine recall. However, if they remain hrHPV positive, cytology negative or inadequate at 24 months, they should be referred to colposcopy.

The cervical cancer screening program has evolved to include HPV testing, which allows for further risk stratification. A negative hrHPV result means a return to normal recall, while a positive result requires cytological examination. Abnormal cytology results lead to colposcopy, while normal cytology results require a repeat test at 12 months. Inadequate samples require a repeat within 3 months, and two consecutive inadequate samples lead to colposcopy. Treatment for CIN typically involves LLETZ or cryotherapy. Individuals who have been treated for CIN should be invited for a test of cure repeat cervical sample 6 months after treatment.

The appropriate medical management for a miscarriage involves administering vaginal misoprostol alone. This is a prostaglandin analogue that stimulates uterine contractions, expediting the passing of the products of conception. Oral methotrexate and oral mifepristone alone are not suitable for managing a miscarriage, as they are used for ectopic pregnancies and terminations of pregnancy, respectively. The combination of oral misoprostol and oral mifepristone, as well as vaginal misoprostol and oral mifepristone, are also not recommended due to limited evidence of their efficacy. The current recommended approach is to use vaginal misoprostol alone, as it limits side effects and has a strong evidence base.

Management Options for Miscarriage

Miscarriage can be a difficult and emotional experience for women. In the 2019 NICE guidelines, three types of management for miscarriage were discussed: expectant, medical, and surgical. Expectant management involves waiting for a spontaneous miscarriage and is considered the first-line option. However, if it is unsuccessful, medical or surgical management may be offered.

Medical management involves using tablets to expedite the miscarriage. Vaginal misoprostol, a prostaglandin analogue, is used to cause strong myometrial contractions leading to the expulsion of tissue. It is important to advise patients to contact their doctor if bleeding does not start within 24 hours. Antiemetics and pain relief should also be given.

Surgical management involves undergoing a surgical procedure under local or general anaesthetic. The two main options are vacuum aspiration (suction curettage) or surgical management in theatre. Vacuum aspiration is done under local anaesthetic as an outpatient, while surgical management is done in theatre under general anaesthetic. This was previously referred to as ‘Evacuation of retained products of conception’.

It is important to note that some situations are better managed with medical or surgical management, such as an increased risk of haemorrhage, being in the late first trimester, having coagulopathies or being unable to have a blood transfusion, previous adverse and/or traumatic experience associated with pregnancy, evidence of infection, and more. Ultimately, the management option chosen should be based on the individual patient’s needs and preferences.

If simple analgesia with paracetamol and NSAIDs is not effective in treating endometriosis symptoms, hormonal treatment with the combined oral contraceptive pill or a progesterone should be considered.

Although a referral to gynaecology may be necessary due to the recurrence of symptoms and potential pelvic/bowel involvement, primary care can offer further treatment options in the meantime. Hormonal treatment is recommended for this patient, and the combined oral contraceptive pill or any of the progesterone options can be used. As the patient plans to start a family soon, a hormonal option that can be quickly reversed is the most suitable.

Buscopan is not an appropriate treatment for endometriosis, as it only provides relief for menstrual cramps and is not a cure. It may be used to alleviate symptoms associated with irritable bowel syndrome.

Injectable depo-provera is not the best option for this patient, as it can delay the return of fertility, which conflicts with her desire to start a family within the next year.

Opioid analgesia is not recommended for endometriosis treatment, as it carries the risk of side effects and dependence. It is not a long-term solution for managing symptoms.

Understanding Endometriosis

Endometriosis is a common condition where endometrial tissue grows outside of the uterus. It affects around 10% of women of reproductive age and can cause chronic pelvic pain, painful periods, painful intercourse, and subfertility. Other symptoms may include urinary problems and painful bowel movements. Diagnosis is typically made through laparoscopy, and treatment options depend on the severity of symptoms.

First-line treatments for symptomatic relief include NSAIDs and/or paracetamol. If these do not help, hormonal treatments such as the combined oral contraceptive pill or progestogens may be tried. If symptoms persist or fertility is a priority, referral to secondary care may be necessary. Secondary treatments may include GnRH analogues or surgery. For women trying to conceive, laparoscopic excision or ablation of endometriosis plus adhesiolysis is recommended, as well as ovarian cystectomy for endometriomas.

It is important to note that there is poor correlation between laparoscopic findings and severity of symptoms, and that there is little role for investigation in primary care. If symptoms are significant, referral for a definitive diagnosis is recommended.

For non-pregnant women with vaginal thrush, the recommended first-line treatment is a single-dose of oral fluconazole. This is based on NICE guidelines for the diagnosis of vaginal candidiasis. The use of clotrimazole intravaginal pessary is only recommended if the patient is unable to take oral treatment due to safety concerns. Oral nystatin is not appropriate for this condition as it is used for oral candidiasis. While topical clotrimazole can be used to treat vaginal candidiasis, it is not the preferred first-line treatment and should only be used if fluconazole is not effective or contraindicated.

Vaginal candidiasis, also known as thrush, is a common condition that many women can diagnose and treat themselves. Candida albicans is responsible for about 80% of cases, while other candida species cause the remaining 20%. Although most women have no predisposing factors, certain factors such as diabetes mellitus, antibiotics, steroids, pregnancy, and HIV can increase the likelihood of developing vaginal candidiasis. Symptoms include non-offensive discharge resembling cottage cheese, vulvitis, itching, vulval erythema, fissuring, and satellite lesions. A high vaginal swab is not routinely indicated if the clinical features are consistent with candidiasis. Treatment options include local or oral therapy, with oral fluconazole 150 mg as a single dose being the first-line treatment according to NICE Clinical Knowledge Summaries. If there are vulval symptoms, a topical imidazole may be added to an oral or intravaginal antifungal. Pregnant women should only use local treatments. Recurrent vaginal candidiasis is defined as four or more episodes per year by BASHH. Compliance with previous treatment should be checked, and a high vaginal swab for microscopy and culture should be performed to confirm the diagnosis. A blood glucose test may be necessary to exclude diabetes, and differential diagnoses such as lichen sclerosus should be ruled out. An induction-maintenance regime involving oral fluconazole may be considered. Induction involves taking oral fluconazole every three days for three doses, while maintenance involves taking oral fluconazole weekly for six months.

The likelihood of cervical ectropion is higher in individuals who take the COCP due to increased levels of oestrogen. Based on the patient’s medical history and examination results, cervical ectropion appears to be the most probable diagnosis. This condition is more prevalent during puberty, pregnancy, and while taking the pill. Endometrial cancer is improbable in a young person, and the presence of cervical ectropion on examination supports this straightforward diagnosis. Although chlamydia infection can cause cervicitis, the patient’s sexual history does not suggest this diagnosis, and the pill remains the most likely cause. It is recommended to undergo STI screenings annually.

Understanding Cervical Ectropion

Cervical ectropion is a condition that occurs when the columnar epithelium of the cervical canal extends onto the ectocervix, where the stratified squamous epithelium is located. This happens due to elevated levels of estrogen, which can occur during the ovulatory phase, pregnancy, or with the use of combined oral contraceptive pills. The term cervical erosion is no longer commonly used to describe this condition.

Cervical ectropion can cause symptoms such as vaginal discharge and post-coital bleeding. However, ablative treatments such as cold coagulation are only recommended for those experiencing troublesome symptoms. It is important to understand this condition and its symptoms in order to seek appropriate medical attention if necessary.

Investigating Infertility: Recommended Tests and Procedures

When a patient presents with infertility, there are several tests and procedures that can be performed to identify the underlying cause. In the case of a patient with known co-morbidities such as previous ectopic pregnancy, pelvic inflammatory disease, or endometriosis, laparoscopy and dye is the most appropriate next step of investigation. This procedure involves Exploratory laparoscopy, allowing direct visualisation of the pelvis, and injection of dye into the uterus to assess tubal patency.

Luteinising hormone (LH) and follicle-stimulating hormone (FSH) testing is typically performed when a patient has irregular menses, but may not be necessary for those with regular cycles and normal mid-luteal progesterone levels indicating ovulation. Basal body temperature charts are not recommended by NICE guidelines, as a mid-luteal phase progesterone blood test is a more accurate measure of ovulation.

Cervical smears may be indicated if the patient is due for screening, but do not form part of infertility investigations. Hysterosalpingography is recommended by NICE guidelines for women without co-morbidities, but is not appropriate for those with a history of endometriosis. Understanding the appropriate tests and procedures for investigating infertility can help healthcare providers identify the underlying cause and develop an effective treatment plan.